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Abstract Ileal bile acid-binding protein (I-BABP) is a 14 kDa
cytosolic protein which binds bile acids with a high a⁄nity. It is
thought to be implicated in the enterohepatic circulation of bile
acids and, hence, in cholesterol homeostasis. Using a combina-
tion of in vivo and in vitro experiments, we have recently shown
that I-BABP gene expression can be indirectly up-regulated by
cholesterol through the activation of sterol-responsive element-
binding protein 1c (SREBP1c) by liver X-receptor (LXR). We
report here that I-BABP can be also a direct target for LXR.
I-BABP regulation by LXR is maintained when the SREBP
binding site is deleted in the I-BABP promoter and occurs, in
the absence of conventional LXRE sequences, through an IR1
sequence previously identi¢ed as a farnesoid X-receptor-respon-
sive element (FXRE). Electrophoretic mobility shift assays dem-
onstrated that the LXR/RXR heterodimer speci¢cally recog-
nizes the FXRE. Collectively, these data strongly suggest that
LXR can regulate the I-BABP gene by both direct and indirect
mechanisms.
2 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Excessive cholesterol content in the Western diet greatly
contributes to the development of vascular strokes of which
the human and social costs are dramatic. Therefore, consid-
erable energy has been devoted for several years to determin-
ing the players responsible for the control of cholesterol (CS)
homeostasis. CS balance is dependent on the equilibrium be-
tween dietary supplies, de novo cellular synthesis and fecal
elimination, essentially as bile acids (BA). Primary BA are
synthesized from CS in the liver in which they are conjugated
with taurine or glycine prior to being secreted into bile. In the
intestinal lumen, they facilitate fat digestion and absorption.
In healthy humans, more than 95% of BA are reabsorbed
along the small intestine and return by the portal route to
the liver to be secreted again into bile. This enterohepatic
circulation is crucial for the maintenance of CS homeostasis.
Indeed, BA not reclaimed by the small intestine constitute the
main physiological way of CS elimination. BA reabsorption is
essentially supported by a speci¢c transport system consti-
tuted of a set of membrane and soluble BA carriers located
in the distal part of the gut (i.e. ileum) [1]. BA uptake mainly
takes place through an active transport supported by the ileal
sodium-dependent bile acid transporter (I-BAT) located in the
brush border membrane of ileocytes [2]. Once in the cell, BA
are reversibly bound to a soluble 14 kDa protein, the ileal bile
acid-binding protein (I-BABP) [3], prior to being secreted into
portal blood by a basolateral transport system constituted of
the multidrug resistance protein 3 [4] and a truncated form of
I-BAT [5].
Photoa⁄nity labeling of ileal tissue demonstrated that
I-BABP is the only physiologically relevant BA carrier found
in the cytosol of ileocytes [6]. Therefore, it is likely that
I-BABP expression levels can be critical for an e⁄cient entero-
hepatic circulation of BA. Indeed, I-BABP is thought to be
involved in BA desorption from the apical plasma membrane,
intracellular tra⁄cking and targeting on the basolateral BA
transport system. In good agreement with this putative critical
role, we have recently shown that the I-BABP gene is tightly
controlled by di¡erent molecular players considered as cellular
sterol sensors. Indeed, I-BABP gene expression is up-regulated
by BA [7,8] through the activation of the nuclear receptor
farnesoid X-receptor (FXR, NR1H4). This regulation requires
the binding of an FXR/9-cis-retinoic acid receptor (RXR)
heterodimer to a speci¢c bile acid-responsive element
(BARE or FXRE) constituted of an inverted hexanucleotide
repeat spaced by one nucleotide (IR1) identi¢ed in the prox-
imal part of the human I-BABP promoter [9]. The dramatic
decrease in the expression levels of the I-BABP gene found in
FXR null mice indicates that this nuclear receptor is a major
regulator for this gene under normal physiological conditions
[10].
I-BABP gene expression has also been found to be induced
by a CS-enriched diet in mice [11]. It is now well established
that CS is a gene modulator. Indeed, the intracellular level of
CS controls the proteolytic activation of transcription factors
termed sterol-responsive element-binding proteins (SREBP).
The activated SREBP recognizes a speci¢c nucleotide se-
quence, the sterol-responsive element (SRE), in the target
genes leading to their transcriptional rate [12]. Moreover,
CS provides metabolic derivatives, BA and oxysterols, which
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are ligand-mediated activators for the nuclear hormone recep-
tors FXR and liver X-receptors (LXRK, NR1H3 or LXRL,
NR1H2), respectively [13]. After identi¢cation of an SRE se-
quence in the proximal promoter of the human I-BABP gene,
we have recently shown that I-BABP regulation by CS occurs
via an indirect pathway involving the LXR-mediated induc-
tion and activation of the SREBP1c isoform [11]. Such indi-
rect regulation by LXR has also been reported for genes of
the lipogenic pathway, stearoyl-CoA desaturase-I [14] and
fatty acid synthase (FAS) [15]. LXRs associated with RXR
preferentially recognize a DNA hormone response element,
termed LXRE, that consist of two direct hexameric repeats
separated by four nucleotides (DR4) found in several target
genes including the SREBP1c gene. The recent demonstration
that LXR and SREBP-binding sites independently but addi-
tively confer LXR responsiveness to the FAS gene [15] led us
to explore the possibility of a direct control of the I-BABP
gene by LXR.
In the current report, we show that I-BABP is also a direct
LXR target gene. This regulation is achieved, in the absence
of a conventional LXRE, by the binding of an LXR/RXR
heterodimer to the FXR-responsive element found in the
proximal promoter of human I-BABP.
2. Materials and methods
2.1. Cell culture and organ culture of ileal explants
Caco-2 cells were cultured in a controlled environment (37‡C, 5%
CO2) in Dulbecco’s modi¢ed Eagle’s medium (DMEM; Invitrogen)
containing 4 mM glutamine, 1% non-essential amino acids, 100 U/ml
penicillin, 100 Wg/ml streptomycin and supplemented with 20% fetal
calf serum (FCS). The medium was changed every 2 days.
Male Swiss mice were fasted overnight and ileal explants were pre-
pared then cultured as previously described [16]. In brief, ileal samples
were rapidly removed, washed, then sliced into strips of which the
serosa was stripped o¡. Ileal explants were pre-cultured for 4 h at
37‡C under an oxygenated atmosphere in HEPES-bu¡ered DMEM
containing 10% NCTC-135, 10% FCS, 1% fungizone and 0.1 mg/ml
gentamicin (all from Gibco-Life Technology). The explants were cul-
tured for 16 h in the same medium supplemented with 5% lipoprotein-
free medium in the presence of LXR agonist (50 WM GW3965, gen-
erous gift of Dr. T.M. Willson, GlaxoSmithKline, Research Triangle
Park, NC, USA). Control cultures received the vehicle alone (2 Wl/ml
dimethyl sulfoxide).
2.2. Northern blot analysis
Total RNAs were isolated with the RNeasy mini kit (Qiagen). 10 Wg
of RNAs were electrophoresed on a 1% agarose gel and transferred to
GeneScreen membrane (NEN Life Science Products) using previously
published procedures [9]. cDNA from human I-BABP was used as
probe [17]. The cDNA from murine 18S rRNA was used to ensure
that equivalent amounts of RNAs were loaded and transferred.
Probes were labeled with [K-32P]dCTP (3000 Ci/mmol; ICN) by a
megaprime kit (Amersham Pharmacia Biotech).
2.3. Plasmid construction and transfection assays
Wild type32769/+44 (I-BABP 2.8wt) and31204/+44 (I-BABP 1.2wt)
bp fragments of the human I-BABP promoter were cloned upstream
of the chloramphenicol acetyltransferase (CAT) gene in the pCAT3-
basic vector (Promega). Deletions of SRE (I-BABP 1.2del SRE) and
FXR-responsive element (I-BABP 1.2del FXREþSRE) were generated by
site-directed mutagenesis (Quickchange1 site-directed mutagenesis
kit, Stratagene) using the following oligonucleotides: 5P-caggacaggag-
ggagaagaagcctcagcaactgggagag-3P and 5P-ggcaatggggtgacagcacttgggg-
cttgtccctccaggt-3P respectively. All constructs were con¢rmed prior
to use by restriction digestion.
Caco-2 cells were used for transfection studies (passage 35^40).
They were plated in 6-well plates in DMEM supplemented with
10% FCS at 40^50% con£uence. Transfection mixes contained 4 Wg
of I-BABP-CAT reporter plasmid and 500 ng of L-galactosidase ex-
pression vector. Cotransfection mixes contained 4 Wg of I-BABP-CAT
reporter plasmid, 250 ng of human LXRK or human LXRL expres-
sion vectors, 250 ng of human RXRK expression vectors and/or 100 ng
of human SREBP1c expression vectors (generous gift from Dr. T.F.
Osborne, University of California, Irvine, CA, USA) and 500 ng of
L-galactosidase expression vector. Cells were transfected overnight by
the calcium phosphate precipitation method. In transfection studies,
the medium was changed to DMEM supplemented with 10% delipi-
dated serum. The cells were incubated for an additional 24 h. Cell
extracts were prepared and assayed for CAT and L-galactosidase ac-
tivities.
2.4. Electrophoretic mobility shift assays
Human LXRK and human RXRK were synthesized in vitro using
the TNT rabbit reticulocyte lysate coupled in vitro transcription/trans-
lation system (Promega) according to the manufacturer’s instructions.
Gel mobility shift assays (20 Wl) contained 20 mM HEPES (pH 7.8),
120 mM KCl, 0.4% Nonidet P-40, 12% glycerol, 2 mM dithiothreitol,
0.2 Wg poly(dI-dC), and freshly synthesized LXRK and RXRK pro-
teins. Competitor oligonucleotides including the wild type or mutated
I-BABP FXRE sequences gatcggccaGGGTGAATAACCTcggg and
gatcggccaGGAAGAATATTCTcgggg (mutations in bold) were added
at a 50-fold excess. After 10 min incubation on ice, 10 ng of 5P end-
labeled [Q32P]ATP oligonucleotide (I-BABP FXREwt or I-BABP
FXREmut) was added, and the incubation continued for an additional
10 min. DNA^protein complexes were resolved on a 4% polyacryl-
amide gel in 0.5 M TBE (90 mM Tris, 90 mM boric acid, 2 mM
EDTA). Gels were dried then subjected to autoradiography at 370‡C.
3. Results and discussion
3.1. An LXR agonist induces I-BABP gene expression ex vivo
Mice subjected to an LXR agonist (GW3965) exhibit an
increase in I-BABP mRNA levels [11]. Nevertheless, this e¡ect
is likely, at least in part, indirect since the LXR-mediated
induction of cholesterol 7K-hydroxylase leads to a rise in
BA synthesis [18]. Therefore, to explore whether the I-BABP
gene may be up-regulated by LXR independently of the BA/
FXR pathway, an ex vivo experiment was performed using
mouse ileal explants cultured in the presence of an LXR ago-
nist. According to previously published data [11], this treat-
ment leads to a slight but signi¢cant rise in I-BABP mRNA
levels demonstrating that I-BABP is an LXR target gene
(Fig. 1).
3.2. LXR can transactivate the human I-BABP promoter
independently of the SREBP-binding site
In a previous study, we have shown that LXR-mediated
regulation of the I-BABP gene takes place through a cascade
of events involving the induction of SREBP1c by LXR pro-
ducing, in turn, the transactivation of the I-BABP gene. This
last step requires an SREBP-binding site (SRE) identi¢ed in
the proximal promoter of human I-BABP [11]. In the present
report, we have hypothesized that the I-BABP promoter
might also be a target for a direct regulation by LXR as
recently depicted for the FAS gene [15].
In a ¢rst experiment, to explore the respective in£uence of
LXRK and LXRL on the transcriptional activity of the
I-BABP gene, Caco-2 cells were transiently co-transfected
with a large human I-BABP promoter fragment
(I-BABP2.8wt) cloned upstream of the CAT reporter gene
and with expression vectors for human LXRK or LXRL
and/or human RXRK. As shown in Fig. 2A, no activity of
the reporter gene was observed with LXRK, LXRL or RXRK
alone. By contrast, a strong transactivation of the reporter
gene was found when LXRK or LXRL was co-transfected
together with RXRK. Since no quantitative di¡erence was
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observed whatever the LXR isoform used, the further experi-
ments were performed with LXRK only. To determine the
promoter regions containing the sequences responsible for
LXR induction, a set of 5P deletion constructs were next real-
ized (Fig. 2B). Interestingly, the LXR-mediated CAT activity
was still fully conserved when the shorter construct was used
demonstrating that the sequence between 3183 and +44 me-
diates the response of the I-BABP promoter to LXR. As this
region contains the SRE site responsible for the indirect reg-
ulation of I-BABP by LXR [11], a deletion experiment was
undertaken to establish if LXR is able to transactivate the
I-BABP promoter independently of the SRE372=362 sequence
(Fig. 2C). The 12-fold induction of CAT activity mediated by
the LXRK/RXRK heterodimer on the wild-type promoter
construct was reduced by 50% when the SRE was deleted.
This gives the ¢rst demonstration that LXR can up-regulate
the I-BABP promoter in the absence of the SRE372=362 se-
quence.
3.3. LXR/RXR heterodimer activates the I-BABP promoter
through the SRE and FXRE sequences
This ¢nding raises the question of the existence of an
LXRE in the proximal promoter of the human I-BABP
gene. The direct regulation of LXR target genes occurs
via a direct hexamer repeat separated by four nucleotides
(DR4 sequence) [19]. Computer analysis of the human
I-BABP3183=þ44 promoter sequence has not made it possible
to identify such a typical DR4 site suggesting the existence of
a non-conventional LXRE. It is noteworthy that an FXRE
known to be a major regulatory site for the I-BABP gene is
found in this promoter sequence [9]. Moreover, it has recently
been shown in the context of phospholipid transfer protein
Fig. 1. LXR agonist induces I-BABP expression in mouse ileal ex-
plants. Ileal explants from male Swiss mice were cultured for 16 h
in medium supplemented with 5% lipoprotein-free serum in the pres-
ence of 50 WM LXR agonist (GW3965). Control received the vehicle
alone. I-BABP mRNA levels were evaluated by Northern blotting
using 10 Wg of total RNA and normalized to 18S rRNA. MeanU
S.E.M.
Fig. 2. Human I-BABP promoter is an LXR target gene. Human enterocyte-like Caco-2 cells (passage 35^40) were transiently transfected in a
10% FCS medium. Twelve hours after the transfection, the cells were cultured for an additional 24 h in medium containing 10% delipidated se-
rum. A: LXRK and LXRL activate the I-BABP2.8wt promoter (32769 to +44 bp). B: LXR responsiveness is located in the proximal human
I-BABP promoter. 5P deletion analysis of the I-BABP promoter. C: Activation of the I-BABP promoter is maintained when the SREBP-bind-
ing site is deleted. CAT activity normalized to L-galactosidase activity. MeanUS.E.M., n=3.
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(PLTP) promoter that the FXRE is a possible binding site for
the LXR/RXR heterodimer [20]. To investigate whether LXR
can also bind to the I-BABP FXRE3160=3148 sequence, elec-
trophoretic mobility shift assays were next carried out (Fig. 3).
In vitro translated LXRK and RXRK proteins and radio-
labeled oligonucleotides corresponding to the wild type
FXRE (hI-BABPFXR wt) or mutated FXRE (hI-BABPFXR mut)
were used. Only the LXRK/RXRK heterodimer binds to
hI-BABPFXR wt (lane 4). Introduction of mutations in the
IR1 sequence (hI-BABPFXR mut) fully abolished the binding
(lane 5). Competition assay using unlabeled oligonucleotides
in excess demonstrated the speci¢city of the LXR/RXR bind-
ing to hI-BABPFXR wt since the formation of the complex was
suppressed in the presence of a 50-fold excess of wild type
hI-BABPFXR wt (lane 6), whereas it is conserved in the pres-
ence of hI-BABPFXR mut (lane 7). All together these data dem-
onstrate that the FXRE can function as an LXRE in the
promoter of the human I-BABP gene.
The existence of di¡erent binding sites for both LXR/RXR
and SREBP in the human I-BABP promoter suggests that
these two families of transcription factors can cooperate in
the regulation of I-BABP gene expression. Co-transfections
of expression vectors encoding LXRK, RXRK and/or active
form SREBP1c in the presence of the wild type I-BABP/CAT
promoter/reporter system were undertaken to explore this hy-
pothesis. As shown in Fig. 4A, the wild type sequence of the
I-BABP promoter (I-BABP 1.2wt) was responsive to LXRK/
RXRK and SREBP1c alone. The combination of these two
transcription factors led to a 25-fold increase in I-BABP 1.2wt
promoter activity. Deletion of the SRE sequence (I-BABP
1.2del SRE) fully abolished the SREBP1c-mediated transactiva-
tion of the reporter gene and reduced the magnitude of
Fig. 3. LXR/RXR heterodimer speci¢cally binds to the FXR-bind-
ing site found in the proximal promoter of the I-BABP gene. Elec-
trophoretic mobility shift assay was performed with in vitro trans-
lated LXRK and RXRK and radiolabeled wild type hI-BABPFXR wt
or mutated hI-BABPFXR mut as probe. Competition analysis was per-
formed with a 50-fold excess of unlabeled hI-BABPFXR wt or hI-
BABPFXR mut.
Fig. 4. LXR/RXR activates I-BABP promoter through SRE and FXRE. Caco-2 cells were transiently transfected with either the I-BABP1.2wt,
I-BABP1.2del FXRE or I-BABP1.2del FXREþSRE promoter^reporter gene constructs, together with expression vectors for LXRK, RXRK and/or ex-
pression vector for SREBP1c. The cells were transfected in 10% FCS medium. Twelve hours after the transfection, the cells were cultured for
an additional 24 h in 10% FCS medium. CAT activity normalized to L-galactosidase activity. MeanUS.E.M., n=3.
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LXRK/RXRK activation. The double deletion of FXRE and
SRE sequences (I-BABP 1.2del FXREþSRE) suppressed all pro-
moter response (Fig. 4B). Collectively, these data are consis-
tent with a synergistic regulation of the I-BABP promoter by
LXR/RXR and SREBP1c.
In conclusion, the I-BABP gene can be directly as well as
indirectly up-regulated by LXR. The coexistence of these two
LXR regulatory pathways has already been found for the
FAS gene which encodes a rate-limiting enzyme in de novo
lipogenesis [15]. Nevertheless, in contrast to FAS, the direct
e¡ect of LXR on I-BABP occurs by the binding of the LXR/
RXR heterodimer to an IR1 sequence previously identi¢ed as
an FXR-binding site in the promoter of the human I-BABP
gene [9]. It is noteworthy that similar data have recently been
reported for the PLTP [20] suggesting that the FXRE se-
quence can function as an LXR-binding site in di¡erent genes.
The physiological signi¢cance of this ¢nding remains to be
determined. It might constitute a redundant system contribut-
ing to the maintenance of I-BABP gene sensitivity to CS
changes via the activation of LXR by oxysterols when FXR
is lacking (e.g. in FXR null mice) or a cross-talk between
LXR and FXR in the regulation of I-BABP gene expression.
Further investigations are required to answer to these ques-
tions. The present result con¢rms that I-BABP gene expres-
sion is tightly regulated by various transcription factors and
nuclear hormone receptors (SREBP, FXR, LXR) considered
to be CS sensors. Although the precise physiological func-
tion(s) of this soluble BA carrier in the ileocyte is not yet fully
established, this new ¢nding strongly suggests that I-BABP
protein is important for the maintenance of CS homeostasis.
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